A New Neuraxial Position Technique " The Anatolian Sitting Position- Sitting Fetal Cross-legged"

November 15, 2018 updated by: Fatma Ferda Kartufan, Yeditepe University

"The Anatolian Sitting Neuraxial Position Technique"; is it Beneficial? A Prospective Clinical Comparison Trial Via Ultrasonography

A prosperous neuraxial anesthesia positioning ensures a raised chance of successful needle placement. The primary aim is to compare "The Anatolian sitting position-ASP" with "The Sitting Fetal Position-SFP" sonographically. Secondary aim is to compare their comfort.

Study Overview

Detailed Description

Fifty participants were included to this prospective, randomized, consecutive controlled clinical study. Six parameters were evaluated in each position; subcutaneous tissue (ST), skin to spinous process (S-SP), transverse diameters of bilateral paraspinal muscles (left paraspinal muscle [LPM] and right paraspinal muscle [RPM]), interspinous gap opening (ISGO), mean of bilateral paraspinal muscles (MPM). The change of every measurement recorded via ultrasonography (USG) according to the positioning techniques (the Anatolian Sitting Position [ASP] could also be named as "sitting fetal cross-legged position" and the Sitting Fetal Position [SFP] which is a traditional sitting position) were also calculated. The calculations are explained briefly in primary outcomes (including the change of ASP-SFP in ST, S-SP, LPM, RPM, MPM, ISGO). Stretcher comfort (SC), position comfort (PC), lumbar comfort (LC), and abdominal comfort (AC) were evaluated by the participants with the 5-point Numerical Rating Scale (NRS).

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • İçerenköy
      • Istanbul, İçerenköy, Turkey
        • Yeditepe University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 41 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healty and adult volunteers,
  • must be able to do the sitting fetal cross-legged position ( ASP ),
  • must be able to do the sitting fetal position ( SFP ).

Exclusion Criteria:

  • BMI higher than 40,
  • Lumbar hernia,
  • Scoliosis,
  • History of spine surgery,
  • History of trauma,
  • History of lower back pain,
  • Arthropathy {especially pelvic or knee problems},
  • Could not be able to do one or both of the two neuraxial position techniques.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: The SFP technique
In the SFP neuraxial positioning technique, fifty participants were planned to sit on the stretcher facing the wall of the sonography room and turned back to the consultant Radiologist with legs hanging freely, forearms on the lap and hand are on the knees. The position is completed with the back curved in the fetal position. Then the USG is performed by the consultant Radiology M.D. in maximum 2 hours time to each participant, and the 5-point NRS evaluation is done by each participant in maximum 30 minutes time until the study ends within 24 weeks.
The USG, and the 5-point NRS evaluation in the SFP
Experimental: The ASP technique
In the ASP neuraxial positioning technique, the same fifty participants were planned to sit on the same part of the stretcher facing the wall of the sonography room and turned back to the consultant Radiologist with legs crossed, forearms of the participants are on the lap and hands are on the knees, and the position is completed with the back curved in the fetal position.Then the USG is performed by the consultant Radiology M.D. in maximum 2 hours time to each participant, and the 5-point NRS evaluation is done by each participant in maximum 30 minutes time until the study ends within 24 weeks.
The USG, and the 5-point NRS evaluation in the ASP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interspinous gap opening (ISGO) measurement in the ASP
Time Frame: For the ASP technique, ISGO is measured in the first 10 minutes(mins.) time, for each participant, through study completion.
the wideness measurement of the ISGO in millimeters via ultrasonography (USG) in the ASP
For the ASP technique, ISGO is measured in the first 10 minutes(mins.) time, for each participant, through study completion.
Left paraspinal muscle (LPM) measurements in the ASP
Time Frame: For the ASP technique, LPM is measured in between 10mins. and 20mins. time, for each participant, through study completion.
the diameter measurement of the LPM in millimeters via ultrasonography in the ASP
For the ASP technique, LPM is measured in between 10mins. and 20mins. time, for each participant, through study completion.
Right paraspinal muscle (RPM) measurements in the ASP
Time Frame: For the ASP technique, RPM is measured in between 20mins. and 30mins. time, for each participant, through study completion.
the diameter measurement of the RPM in millimeters via ultrasonography in the ASP
For the ASP technique, RPM is measured in between 20mins. and 30mins. time, for each participant, through study completion.
The mean of bilateral paraspinal muscles (MPM) in the ASP
Time Frame: For the ASP technique, MPM measurement is planned to be done in between 30mins. and 40mins. time, for each participant, through study completion.
Measured by ( [LPM+RPM]/2) in millimeters in the ASP
For the ASP technique, MPM measurement is planned to be done in between 30mins. and 40mins. time, for each participant, through study completion.
Subcutaneous tissue (ST) measurements in the ASP
Time Frame: For the ASP technique, ST measurement is planned to be done in between 40mins. and 50mins. time, for each participant, through study completion.
the thickness measurement of the subcutaneous tissue in millimeters via ultrasonography in the ASP
For the ASP technique, ST measurement is planned to be done in between 40mins. and 50mins. time, for each participant, through study completion.
The skin to spinous process (S-SP) measurements in the ASP
Time Frame: For the ASP technique, S-SP measurement is planned to be done in between 50mins. and 1 hour(hr.) time, for each participant, through study completion.
the depth measurement of the skin to spinous process in millimeters via ultrasonography in the ASP
For the ASP technique, S-SP measurement is planned to be done in between 50mins. and 1 hour(hr.) time, for each participant, through study completion.
Interspinous gap opening (ISGO) measurement in the SFP
Time Frame: For the SFP technique, ISGO measurement is planned to be done, right after NRS evaluation of the ASP, in between 1hr.10mins. and 1hr.20mins. time, for each participant, through study completion.
the wideness measurement of the ISGO in millimeters via ultrasonography in the SFP
For the SFP technique, ISGO measurement is planned to be done, right after NRS evaluation of the ASP, in between 1hr.10mins. and 1hr.20mins. time, for each participant, through study completion.
Left paraspinal muscle (LPM) measurements in the SFP
Time Frame: For the SFP technique, LPM measurement is planned to be done in between 1hr.20mins. and 1hr.30mins. time, for each participant, through study completion.
the diameter measurement of the LPM in millimeters via ultrasonography in the SFP
For the SFP technique, LPM measurement is planned to be done in between 1hr.20mins. and 1hr.30mins. time, for each participant, through study completion.
Right paraspinal muscle (RPM) measurements in the SFP
Time Frame: For the SFP technique, RPM measurement is planned to be done in between 1hr.30mins. and 1hr.40mins. time, for each participant, through study completion.
the diameter measurement of the RPM in millimeters via ultrasonography in the SFP
For the SFP technique, RPM measurement is planned to be done in between 1hr.30mins. and 1hr.40mins. time, for each participant, through study completion.
The mean of bilateral paraspinal muscles (MPM) in the SFP
Time Frame: For the SFP technique, MPM measurement is planned to be done in between 1hr.40mins. and 1hr.50mins. time, for each participant, through study completion.
Measured by ( [LPM+RPM]/2) in millimeters in the SFP
For the SFP technique, MPM measurement is planned to be done in between 1hr.40mins. and 1hr.50mins. time, for each participant, through study completion.
Subcutaneous tissue (ST) measurements in the SFP
Time Frame: For the SFP technique, ST measurement is planned to be done in between 1hr.50mins. and 2hrs. time, for each participant, through study completion.
the thickness measurement of the subcutaneous tissue in millimeters via ultrasonography in the SFP
For the SFP technique, ST measurement is planned to be done in between 1hr.50mins. and 2hrs. time, for each participant, through study completion.
The skin to spinous process (S-SP) measurements in the SFP
Time Frame: For the SFP technique, S-SP measurement is planned to be done in between 2hrs. and 2hr.10mins. time, for each participant, through study completion.
the depth measurement of the skin to spinous process in millimeters via ultrasonography in the SFP
For the SFP technique, S-SP measurement is planned to be done in between 2hrs. and 2hr.10mins. time, for each participant, through study completion.
the change of ISGO (ISGO ASP-SFP)
Time Frame: ISGO in the ASP is measured in the first 10mins., and ISGO in the SFP is measured in between 1hr.10 mins. and 1hr.20mins. time, through study completion.
Measured by calculation; ([ISGO in the ASP in millimeters]-[ISGO in the SFP in millimeters])
ISGO in the ASP is measured in the first 10mins., and ISGO in the SFP is measured in between 1hr.10 mins. and 1hr.20mins. time, through study completion.
the change of LPM (LPM ASP-SFP)
Time Frame: LPM in the ASP is measured in between 10mins. and 20mins. time, and LPM in the SFP is measured in between 1hr.20mins and 1hr.30mins. time, through study completion.
Measured by calculation; ([LPM in ASP in millimeters]-[LPM in SFP in millimeters])
LPM in the ASP is measured in between 10mins. and 20mins. time, and LPM in the SFP is measured in between 1hr.20mins and 1hr.30mins. time, through study completion.
the change of RPM (RPM ASP-SFP)
Time Frame: RPM in the ASP is measured in between 20mins. and 30mins. time, and RPM in the SFP is measured in between 1hr.30mins. and 1hr.40mins. time, through study completion.
Measured by calculation ([RPM in ASP in millimeters]-[RPM in SFP in millimeters])
RPM in the ASP is measured in between 20mins. and 30mins. time, and RPM in the SFP is measured in between 1hr.30mins. and 1hr.40mins. time, through study completion.
the change of MPM (MPM ASP-SFP)
Time Frame: MPM in the ASP is measured in between 30mins. and 40mins. time, and MPM in the SFP is measured in between 1hr.40mins and 1hr.50mins. time, through study completion.
Measured by calculation ([MPM in ASP in millimeters]-[MPM in SFP in millimeters])
MPM in the ASP is measured in between 30mins. and 40mins. time, and MPM in the SFP is measured in between 1hr.40mins and 1hr.50mins. time, through study completion.
the change of ST (ST ASP-SFP)
Time Frame: ST in the ASP is measured in between 40mins. and 50mins. time, and in the SFP is measured in between 1hr.50mins and 2hrs. time, through study completion.
Measured by calculation ([ST in ASP in millimeters]-[ST in SFP in millimeters])
ST in the ASP is measured in between 40mins. and 50mins. time, and in the SFP is measured in between 1hr.50mins and 2hrs. time, through study completion.
the change of S-SP (S-SP ASP-SFP)
Time Frame: S-SP in the ASP is measured in between 50mins. and 1hr. time, and S-SP in the SFP is measured in between 2 hrs. and 2hrs.10mins. time, through study completion.
Measured by calculation ([S-SP in ASP in millimeters]-[S-SP in SFP in millimeters])
S-SP in the ASP is measured in between 50mins. and 1hr. time, and S-SP in the SFP is measured in between 2 hrs. and 2hrs.10mins. time, through study completion.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort evaluation in the ASP via 5-point numerical rating scale (NRS)
Time Frame: NRS measurement is planned to be done right after the ASP position in between 1hr. and 1hr.10mins. time, for each participant, through study completion.
Comfort evaluation of the ASP technique is planned to be done by the participant right after USG. The 5-point NRS includes 5 scale. The minimum scale is"1" means poor, "2" means fair, "3" means good, "4" means very good, and the maximum scale is "5" means excellent.
NRS measurement is planned to be done right after the ASP position in between 1hr. and 1hr.10mins. time, for each participant, through study completion.
Comfort evaluation in the SFP via 5-point numerical rating scale (NRS)
Time Frame: NRS measurement is planned to be done right after the SFP position in between 2hrs.10mins. and 2hrs.20mins. time, for each participant, through study completion.
Comfort evaluation of the SFP technique is planned to be done by the participant right after USG. The 5-point NRS includes 5 scale. The minimum scale is"1" means poor, "2" means fair, "3" means good, "4" means very good, and the maximum scale is "5" means excellent.
NRS measurement is planned to be done right after the SFP position in between 2hrs.10mins. and 2hrs.20mins. time, for each participant, through study completion.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ferda kartufan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Actual)

September 20, 2018

Study Completion (Actual)

September 20, 2018

Study Registration Dates

First Submitted

October 26, 2018

First Submitted That Met QC Criteria

November 11, 2018

First Posted (Actual)

November 15, 2018

Study Record Updates

Last Update Posted (Actual)

November 16, 2018

Last Update Submitted That Met QC Criteria

November 15, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, Conduction

Clinical Trials on The SFP technique

Subscribe